American pharmacy giant Walgreens has decided to stop selling Pathway Genomics’ home genetic testing kit after the FDA sent the kit manufacturer a letter warning that the tests were not federally approved. In a letter to James Plante, founder and CEO of Pathway Genomics, the FDA said the kit “appears to meet the definition of a [medical] device,” and is thus subject to regulation.

Share this: